Filtres
Territorial licensing: "start at the end before you begin"
Patent pools: an easy licensing option for COVID-19 drugs and SARS CoV 2 vaccines?
An exploration of patent pools, R&D and current initiatives.
2 de 6 Publications
Termination, force majeure and frustration – international perspectives on the life sciences sector
COVID-19 and life sciences M&A
Special approvals of the Federal Institute for Drugs and Medical Devices for the distribution of medical devices and FFP breathing masks without an expiration valve
Restrictions for patents owners to preserve the public interest in the sufficient availability of necessary medicinal products
GDPR and life sciences – part 2
Personal protective equipment COVID-19 export restrictions
GDPR and private sector life sciences
National perspectives on the CJEU Bayer decision
Medical devices and managing product liability risks